|Title:|| Use of 11,28-dioxa-4-azatricyclo[188.8.131.52.sup.4,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them|
|Abstract:||New use of 11,28-dioxa-4-azatricyclo[184.108.40.206.sup.4,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them The compounds of formula I, ##STR1## have been found to have excellent topical activity. They are thus indicated for use in the topical treatment of inflammatory and hyperpoliferative skin diseases and of cutaneous manifestations of immunologically-induced illnesses, such as psoriasis.|
|Inventor(s):|| Grassberger; Maximilian (Vienna, AT), Meingassner; Josef G. (Perchtoldsdorf, AT), Stutz; Anton (Vienna, AT), Stutz; Peter (Vienna, AT) |
|Assignee:|| Sandoz Ltd. (Basel, CH) |
|Filing Date:||Nov 30, 1992|
|Claims:||1. A method of topically treating psoriasis in a mammal in need of said treatment, which comprises administering topically to said mammal in an amount effective for the treament of psoriasis a compound of formula I: ##STR4## wherein R.sup.1 is optionally protected hydroxy, |
R.sup.2 is hydrogen or optionally protected hydroxy,
R.sup.3 is methyl, ethyl, propyl or allyl,
n is 1 or 2 and
the symbol of a line and dotted line is a single bond or a double bond,
in free form or in pharmacuetically acceptable salt form.
2. The method according to claim 1 in which the compound is: ##STR5## in free form or in pharmaceutically acceptable salt form.
3. A method according to claim 1 in which the compound is administered 2 to 5 times daily in the form of a lotion, gel, or cream comprising 1 to 3% of the compound.